Advertisement

Cryptococcus neoformans

  • Vassil St. Georgiev
Chapter
  • 119 Downloads
Part of the Infectious Disease book series (ID)

Abstract

Cryptococcus neoformans is a yeast-like fungus that is pathogenic to both animals and man. It was first isolated in 1894 by Busse (1) from a patient with osteomyelitis of the tibia. The fungus is a saprophitic organism that can be found in soil, on a variety of fruits, as well as in close association with pigeon nests (2,3). There are two varieties of C. neoformans: C. neoformans var. neoformans and C. neoformans var. gattii. Each of these varieties, in turn, has two serotypes: A and D for var. neoformans, and B and C for var. gattii. In addition, there have been reports of human infections caused by two other Cryptococcus species: C. albidus and C. laurentii.

Keywords

Acquire Immunodeficiency Syndrome Cryptococcus Neoformans Cryptococcal Meningitis Oral Fluconazole Cryptococcal Infection 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Busse, O. Über Parasitare zelleinschlusse and ihre Zuchtung. Centralbl. Bakt, 16, 175, 1894.Google Scholar
  2. 2.
    Colmers, R. A„ Irniger, W., and Steinberg, D. H. Cryptococcus neoformans endocarditis cured by amphotericin. J. Am. Med. Assoc, 199, 762, 1967.CrossRefGoogle Scholar
  3. 3.
    Arasteh, K., Staib, F., Grosse, G., Futh, U., and L’ Age, M. Cryptococcosis in HIV infection of man: an epidemiological and immunological indicator? Zentralbl. Bakteriol, 284, 153, 1996.PubMedCrossRefGoogle Scholar
  4. 4.
    Littman, M. C. and Walter, J. E. Cryptococcosis: current status. Am. J. Med, 45, 922, 1968.PubMedCrossRefGoogle Scholar
  5. 5.
    Sabetta, J. R., and Andriole, V. T. Cryptococcal infection of the central nervous system. Med. Clin. North Am., 69, 333, 1985.Google Scholar
  6. 6.
    Butler, W. T., Ailing, D. W., Spickard, A., and Utz, J. P. Diagnostic and prognostic value of clinical and laboratory findings in cryptococcal meningitis. N. Engl. J. Med, 270, 59, 1964.PubMedCrossRefGoogle Scholar
  7. 7.
    De Wytt, C. N., Dickson, P. L., and Holt, G. W. Cryptococcal meningitis: a review of 32 years’ experience. J. Neurol. Sci, 53, 283, 1982.PubMedCrossRefGoogle Scholar
  8. 8.
    Sarosi, G. A., Parker, J. D., Doto, I. L., and Tosh, F. E. Amphotericin B in cryptococcal meningitis: long-term results of treatment. Ann. Intern. Med, 71, 1079, 1969.PubMedGoogle Scholar
  9. 9.
    Spickard, A., Butler, W. T., Andriole, V., and Utz, J. P. The improved prognosis of cryptococcal meningitis with amphotericin B therapy. Ann. Intern. Med, 58, 66, 1963.PubMedGoogle Scholar
  10. 10.
    Utz, J. P., Garriques, I. L., Sande, M. A., et al. Therapy of cryptococcosis with a combination of flucytosine and amphotericin B. J. Infect. Dis, 132, 368, 1975.PubMedCrossRefGoogle Scholar
  11. 11.
    Zimmerman, L. E. and Rappaport, H. Occurence of cryptococcosis in patients with malignant disease of the reticuloendothelial system. Am. J. Clin. Pathol, 24, 1050, 1954.PubMedGoogle Scholar
  12. 12.
    Perfect, J. R., Durack, D. T., and Gallis, H. A. Cryptococcemia. Medicine (Baltimore), 62, 98, 1983.Google Scholar
  13. 13.
    Graybill, J. R. and Alford, R. H. Cell-mediated immunity in cryptococcosis. Cell. Immunol, 14, 12, 1974.PubMedCrossRefGoogle Scholar
  14. 14.
    Schimpff, S. C. and Bennett, J. E. Abnormalities in cell-mediated immunity in patients with C. neoformans infections. J. Allergy Clin. Immunol, 55, 430, 1975.PubMedCrossRefGoogle Scholar
  15. 15.
    Krick, J. A. Familial cryptococcal meningitis. J. Infect. Dis, 143, 133, 1981.PubMedCrossRefGoogle Scholar
  16. 16.
    Ieong, M. H., Reardon, C. C., Levitz, S. M., and Kornfeld, H. Human immunodeficiency virus type 1 infection of alveolar macrophages impairs their innate fungicidal activity. Am. J. Respir. Crit. Care Med, 162 (3 Pt. 1), 966–970, 2000.Google Scholar
  17. 17.
    Mambula, S. S., Simons, E. R., Hastey, R. P., and Levitz, S. M. Human neutrophil-mediated nonoxidative antifungal activity against Cryptococcus neoformans. Abstr. 99th Abstr. Gen. Meet. Am. Soc. Microbiol, May 30—June 3, 303, abstract F-42, 1999.Google Scholar
  18. 18.
    Aguirre, K., Havell, E. A., Gibson, G. W., and Johnson, L. L. Role of tumor necrosis factor and gamma interferon in acquired resistance to Cryptococcus neoformans in the central nervous system of mice. Infect. Immun, 63, 1725, 1995.PubMedGoogle Scholar
  19. 19.
    Kawakami, K., Koguchi, Y., Qureshi, M. H., et al. IL-18 contributes to host resistance against infection with Cryptococcus neoformans in mice with defective IL-12 synthesis through induction of IFN-gamma production by NK cells. J. Immunnol, 165, 941–947, 2000.Google Scholar
  20. 20.
    Watanabe, H., Inukai, A., Doyu, M., and Sobue, G. CNS cryptococcosis with idiopathic CD4+ T lymphocytopenia. Rinsho Shinkeigaku, 40, 249–253, 2000.PubMedGoogle Scholar
  21. 21.
    Kerkering, T. M., Duma, R. J., and Shadomy, S. The evolution of pulmonary cryptococcosis. Ann. Intern. Med, 94, 611, 1981.PubMedGoogle Scholar
  22. 22.
    Reblin, T., Meyer, A., Albrecht, H., and Greten, H. Disseminated cryptococcosis in a patient with AIDS. Mycoses, 37, 275, 1994.PubMedCrossRefGoogle Scholar
  23. 23.
    Sarosi, G. A., Silberfarb, P. M., and Tosh, F. E. Cutaneous cryptococcosis: a sentinel of disseminated disease. Arch. Dermatol, 104, 1, 1971.PubMedCrossRefGoogle Scholar
  24. 24.
    Srur, E., Misad, C., and Henriquez, A. Extrameningeal cryptococcosis in a patient with AIDS. Rev. Med. Chil, 123, 1009, 1995.PubMedGoogle Scholar
  25. 25.
    Houston, S., Lipp, K., Cobian, L., and Sinnott, J. T. Skin rash in a renal transplant recipients. Hosp. Pract. (Off. Ed.), 30, 89, 1995.Google Scholar
  26. 26.
    Haight, D. O., Esperanza, L. E., Greene, J. N., et al., Case report: cutaneous manifestations of cryptococcosis. Am. J. Med. Sci, 308, 192, 1994.PubMedCrossRefGoogle Scholar
  27. 27.
    Abraham, K. A., Little, M. A., Casey, R., Smyth, E., and Walshe, J. J. A novel presentation of cryptococcal infection in a renal allograft recipient. Ir. Med. J, 93, 82–84, 2000.PubMedGoogle Scholar
  28. 28.
    Gosling, H. R. and Gilmer, W. S. Skeletal cryptococcosis: report of a case and review of the literature. J. Bone Joint Surg, 38A, 660, 1956.PubMedGoogle Scholar
  29. 29.
    Hinchey, W. W. and Someren, A. Cryptococcal prostatis. Am. J. Clin. Pathol, 75, 257, 1981.Google Scholar
  30. 30.
    Randal, R. E. Jr., Stacy, W. K., Prout, G. R. Jr., et al. Cryptococcal pyelonephritis. N. Engl. J. Med, 279, 60, 1968.CrossRefGoogle Scholar
  31. 31.
    Okun, E. and Butler, W. T. Ophthalmologic complications of cryptococcal meningitis. Arch. Ophthalmol, 71, 52, 1964.PubMedCrossRefGoogle Scholar
  32. 32.
    Weiss, C., Perry, I. H., and Shevky, M. C. Infections of the human eye with Cryptococcus neoformans (Torula histolytica). Arch. Ophthalmol, 39, 739, 1948.CrossRefGoogle Scholar
  33. 33.
    Procknow, J. J., Benfield, J. R., Ripon, J. W., Diener, C. F., and Archer, F. L. Cryptococcal hepatitis presenting as a surgical emergency. J. Am. Med. Assoc, 191, 269, 1965.CrossRefGoogle Scholar
  34. 34.
    Sabesin, S. M., Fallon, H. J., and Andriole, V. T. Hepatic failure as a manifestation of cryptococcosis. Arch. Intern. Med, 111, 661, 1963.PubMedCrossRefGoogle Scholar
  35. 35.
    Goenka, M. K., Mehta, S., Yachha, S., Nagi, B., Chakraborty, A., Malik, A. K. Hepatic involvement culminating in cirrhosis in a child with disseminated cryptococcosis. J. Clin. Gastroenterol, 20, 57, 1995.PubMedCrossRefGoogle Scholar
  36. 36.
    Baker, R. D. and Haugen, R. K. Tissue damages and tissue diagnosis in cryptococcosis. Am. J. Clin. Pathol, 25, 14, 1955.PubMedGoogle Scholar
  37. Bowman, H. E. and Ritchey, J. O. Cryptococcosis (torulosis) involving brain, adrenal, and prostate. J. Urol,71, 373, I954.Google Scholar
  38. 38.
    Voyles, G. O. and Beck, E. M. Systemic infection due to Torula histolytica (C. hominis): report of four cases and review of the literature. Arch. Intern. Med, 77, 504, 1946.CrossRefGoogle Scholar
  39. 39.
    Zelman, S., O’Neil, H., and Plaut, A. Disseminated visceral torulosis without nervous system involvement with clinical appearance of granulocytic leukemia. Am. J. Med, 11, 568, 1951.CrossRefGoogle Scholar
  40. 40.
    Poliner, J. R., Wilkins, E. B., and Fernald, G. W. Localized osseous cryptococcosis. J. Pediatr, 94, 597, 1979.PubMedCrossRefGoogle Scholar
  41. 41.
    Goldman, M. and Pottage, J. C. Jr. Cryptococcal infection of the breast. Clin. Infect. Dis, 21, 1166, 1995.PubMedCrossRefGoogle Scholar
  42. 42.
    Merwaha, R. K., Trehan, A., Jayashree, K., and Vasishta, R. K. Hypereosinophilia in disseminated cryptococcal disease. Pediatr. Infect. Dis. J, 14, 1103, 1995.Google Scholar
  43. 43.
    Larsen, R. A., Bozzette, S., McCutchan, J. A., et al. Persistent Cryptococcus neoformans infection of the prostate after successful treatment of meningitis. Ann. Intern. Med, 111, 125, 1989.PubMedGoogle Scholar
  44. 44.
    Fuse, H., Ohkawa, M., Yamaguchi, K., Hirata, A., and Matsubara, F. Cryptococcal prostatitis in a patient with Behcet’s disease treated with fluconazole. Mycopathologia, 130, 147, 1995.PubMedCrossRefGoogle Scholar
  45. 45.
    Glassman, S. J. and Hale, M. J. Cutaneous cryptococcosis and Kaposi’s sarcoma occuring in the same lesions in a patient with the acquired immunodeficiency syndrome. Clin. Exp. Dermatol, 20, 480, 1995.PubMedCrossRefGoogle Scholar
  46. 46.
    Muccioli, C., Belfort Junior, R., Neves, R., and Rao, N. Limbal and choroidal Cryptococcus infection in the acquired immunodeficiency syndrome. Am. J. Ophthalmol, 120, 539, 1995.PubMedGoogle Scholar
  47. 47.
    Benard, G., Gryschek, R. C., Duarte, A. J., and Shakanai-Yasuda, M. A. Cryptococcosis as an opportunistic infection in immunodeficiency secondary to paracoccidioidomycosis. Mycopathologia, 133, 65, 1996.PubMedCrossRefGoogle Scholar
  48. 48.
    Molnar-Nadasdy, G., Haesly, I., Reed, J., and Altshuler, G. Placental cryptococcosis in a mother with systemic lupus erythematosus. Arch. Pathol. Lab. Med, 118, 757, 1994.PubMedGoogle Scholar
  49. 49.
    Zuger, A., Louie, E., Holzman, R. S., Simberkoff, M. S., and Rahal, J. J. Cryptococcal disease in patients with acquired immunodeficiency syndrome: diagnostic features and outcome of treatment. Ann. Intern. Med, 104, 234, 1986.PubMedGoogle Scholar
  50. 50.
    Kovacs, J. A., Kovacs, A. A., Polis. M., et al. Cryptococcosis in the acquired immunodeficiency syndrome. Ann. Intern. Med, 103, 533, 1985.PubMedGoogle Scholar
  51. 51.
    Dismukes, W. E., Cloud, G., Gallis, H. A., et al. Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks. N. Engl. J. Med, 317, 334, 1987.PubMedCrossRefGoogle Scholar
  52. 52.
    Eng, R. H.K., Bishburg, E., Smith, S. M., and Kapila, R. Cryptococcal infections in patients with acquired immune deficiency syndrome. Am. J. Med, 81, 19, 1986.CrossRefGoogle Scholar
  53. 53.
    Theunissen, A. W. J. and Zanen, H. C. Dertig petienten net een “verborgen” ziekte: cryptococcen-meningitis. Ned. Tijdschr. Geneeskd, 131, 1123, 1987.Google Scholar
  54. 54.
    Castro Guardiola, A., Ocana Rivera, I., Gasser Laguna, I., et al. 16 cases of infections by Cryptococcus neoformans in patients with AIDS. Enferm. Infec. Microbiol. Clin, 9, 90, 1991.Google Scholar
  55. 55.
    Sugar, A. M. Overview: cryptococcosis in the treatment of AIDS. Mycopathologia, 114, 153, 1991.PubMedCrossRefGoogle Scholar
  56. 56.
    Fur, B. Cryptococcosis in AIDS: therapeutic concepts. Mycoses, 33 (Suppl.1), 55, 1990.Google Scholar
  57. 57.
    Kirchner, J. T. Opportunistic fungal infections in patients with HIV disease: combating cryptococcosis and histoplasmosis. Postgrad. Med, 99, 209, 1996.PubMedGoogle Scholar
  58. 58.
    Mitchell, T. G. and Perfect, J. R. Cryptococcosis in the era of AIDS: 100 years after the discovery of Cryptococcus neoformans. Clin. Microbiol. Rev, 8, 515, 1995.Google Scholar
  59. 59.
    Just-Nübling, G. Therapy of candidiasis and cryptococcosis in AIDS. Mycoses, 37 (Suppl. 2), 56, 1994.PubMedGoogle Scholar
  60. 60.
    Emmons III, W. W., Luchsinger, S., and Miller, L. Progressive pulmonary cryptococcosis in a patient who is immunocompetent. South. Med. J, 88, 657, 1995.PubMedCrossRefGoogle Scholar
  61. 61.
    Munoz-Peréz, M. A., Colmenero, M. A., Rodriguez-Pichardo, A., Rodriguez-Pinero, F. J., Rios, J. J., and Camacho, F. Disseminated cryptococcosis presenting as moluscum-like lesions as the first manifestation of AIDS. Int. J. Dermatol, 35, 646, 1996.PubMedCrossRefGoogle Scholar
  62. 62.
    Gonzalez, C. E., Shetty, D., Lewis, L. L., Mueller, B. U., Pizzo, P. A., and Walsh, T. J. Cryptococcosis in human immunodeficiency virus-infected children. Pediatr. Infect. Dis. J, 15, 796, 1996.PubMedCrossRefGoogle Scholar
  63. 63.
    Littman, M. L. and Zimmerman, L. E. Cryptococcosis. Grune Stratton, New York, 1956.Google Scholar
  64. 64.
    Haugen, R. K. and Baker, R. D. The pulmonary lesions in cryptococcosis with special reference to subpleural nodules. Am. J. Clin. Pathol, 24, 1381, 1954.PubMedGoogle Scholar
  65. 65.
    Talerman, A., Bradley, J. M., and Woodland, B. Cryptococcal lymphadenitis. J. Med. Microbiol, 3, 633, 1970.PubMedCrossRefGoogle Scholar
  66. 66.
    Salyer, W. R., Salyer, D. C., and Baker, R. D. Primary complex of Cryptococcus and pulmonary lymph nodes. J. Infect. Dis., 130, 74, 1974.Google Scholar
  67. 67.
    Houk, V. N. and Moser, K. M. Pulmonary cryptococcosis: must all receive amphotericin B. Ann. Intern. Med, 63, 583, 1965.Google Scholar
  68. 68.
    Campbell, G. D. Primary pulmonary cryptococcosis. Am. Rev. Respir. Dis, 94, 236, 1966.Google Scholar
  69. 69.
    Duperval, R., Hermans, P. E., Brewer, N. S., and Roberts, G. D. Cryptococcosis with emphasis on the significance of isolation of C. neoformans from the respiratory tract. Chest, 72, 13, 1977.PubMedCrossRefGoogle Scholar
  70. 70.
    Hammerman, K. J., Powell, K. E., and Christianson, C. S. Pulmonary cryptococcosis: clinical forms and treatment - CDC cooperative mycoses study. Am. Rev. Respir. Dis, 108, 1116, 1973.PubMedGoogle Scholar
  71. 71.
    Gurevitz, O., Goldschmiedt-Reuven, A., Block, C., Kopolovic, J., Farfel, Z., and Hassin, D. Cryptococcus neoformans vertebral osteomyelitis. J. Med. Vet. Mycol, 32, 315, 1994.PubMedCrossRefGoogle Scholar
  72. 72.
    Anthony, S. A. and Anthony, S. J. Primary cutaneous cryptococcosis in nonimmunocompromised patients. Cutis, 56, 96, 1995.Google Scholar
  73. 73.
    Gordon, P. M., Ormerod, A. D., Harvey, G., Atkinson, P., and Best, P. V. Cutaneous cryptococcal infection without immunodeficiency. Clin. Exp. Dermatol, 19, 181, 1994.PubMedCrossRefGoogle Scholar
  74. 74.
    Mahida, P., Morar, R., Goolam Mohamed, A., Song, E., Tissandie, J. P., and Feldman, C. Cryptococcosis: an unusual cause of endobronchial obstruction. Eur. Respir. J, 9, 837, 1996.PubMedCrossRefGoogle Scholar
  75. 75.
    Schepelmann, K., Muller, F., and Dichgans, J. Cryptococcal meningitis with severe visual and hearing loss and radiculopathy in a patient without immunodeficiency. Mycoses, 36, 429, 1993.PubMedCrossRefGoogle Scholar
  76. 76.
    Vender, J. R., Miller, D. M., Roth, T., Nair, S., and Reboli, A. C. Intraventricular cryptococcal cysts. AJNR Am. J. Neuroradiol, 17, 110, 1996.PubMedGoogle Scholar
  77. 77.
    Yu, F. C., Perng, W. C., Wu, C. P., Shen, C. Y., and Lee, H. S. Adult respiratory distress syndrome caused by pulmonary cryptococcosis in an immunocompetent host: a case report. Chung Hua I Hsueh Tsa Chih (Taipei), 52, 120, 1993.Google Scholar
  78. 78.
    Hellman, R. N., Hinrichs, J., Sicard, G., Hoover, R., Golden, P., and Hoffsten, P. Cryptococcal pyelonephritis and disseminated cryptococcosis in a renal transplant recipient. Arch. Intern. Med, 141, 128, 1984.CrossRefGoogle Scholar
  79. 79.
    Liss, H. P. and Rimland, D. Asymptomatic cryptococcal meningitis. Am. Rev. Respir. Dis, 124, 88, 1981.Google Scholar
  80. 80.
    Tarala, R. A. and Smith, J. D. Cryptococcosis treated by rapid infusion of amphotericin B. Br. Med. J., 281, 28, 1980.Google Scholar
  81. 81.
    Mosberg, W. H. and Arnold, J. G. Torulosis of the central nervous system: review of the literature and report of five cases. Ann. Intern. Med, 32, 1153, 1950.PubMedGoogle Scholar
  82. 82.
    Beeson, P. B. Cryptococcal meningitis of nearly sixteen years’ duration. Arch. Intern. Med, 89, 797, 1952.CrossRefGoogle Scholar
  83. 83.
    Campbell, G. D., Carrier, R. D., and Busey, J. F. Survival in untreated cryptococcal meningitis. Neurology, 31, 1154, 1981.CrossRefGoogle Scholar
  84. 84.
    Carton, C. A. and Mount, L. A. Neurosurgical aspects of cryptococcosis. J. Neurosurg, 8, 143, 1951.PubMedCrossRefGoogle Scholar
  85. 85.
    Powderly, W. G. Recent advances in the management of cryptococcal meningitis in patients with AIDS. Clin. Infect. Dis, 22 (suppl. 2), S119, 1996.PubMedCrossRefGoogle Scholar
  86. 86.
    Dismukes, W. E. Management of cryptococcosis. Clin. Infect. Dis, 17(Suppl. 2), S507, 1993 [see also: Clin. Infect. Dis, 19, 975, 1994 ].Google Scholar
  87. 87.
    Powderly, W. G. Current approach to the acute management of cryptococcal infections. J. Infect, 41, 18–22, 2000.PubMedCrossRefGoogle Scholar
  88. 88.
    Saag, M. S., Graybill, R. J., Larsen, R. A., et al. Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America. Clin. Infect. Dis, 30, 710–718, 2000.PubMedCrossRefGoogle Scholar
  89. 89.
    Van der Horst, C., Saag, M., Cloud, G., et al. Randomized double blind comparison of amphotericin B (AMB) plus flucytosine to AMB alone (step 1) followed by a comparison of fluconazole to itraconazole (step 2) in the treatment of acute cryptococcal meningitis in patients with AIDS. Part I, 35th Intersci. Conf. Antimicrob. Agents Chemother, American Society for Microbiology, Washington, DC, abstract I - 216, 1995.Google Scholar
  90. 90.
    Nightingale, S. D. Initial therapy for acquired immunodeficiency syndrome-associated cryptococcosis with fluconazole. Arch. Intern. Med, 13, 538, 1995.CrossRefGoogle Scholar
  91. 91.
    Saag, M. S., Powderly, W. G., Cloud, G. A., et al. Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. N. Engl. J. Med, 326, 83, 1992.PubMedCrossRefGoogle Scholar
  92. 92.
    Haubrich, R. H., Haghighat, D., Bozzette, S. A., Tilles, J., and McCutchan, J. A. High-dose fluconazole for treatment of cryptococcal disease in patients with human immunodeficiency virus infection. J. Infect. Dis, 170, 238, 1994.PubMedCrossRefGoogle Scholar
  93. 93. Meyohas, M. C., Meynard, J. L., Bollens, D., et al. Treatment of non-meningeal cryptococcosis in patients with AIDS J. Infect.33, 7, 1996Google Scholar
  94. 94.
    Sitbon, O., Fourme, T., Bouree, P., Du Pasquier, L., and Salmeron, S. Successful treatment of disseminated Cryptococcusis with high-dose oral fluconazole. AIDS, 7, 1685, 1993.Google Scholar
  95. 95.
    Ammassari, A., Linzalone, A., Murri, R., Marasca, G., Morace, G., and Antinori, A. Fluconazole for primary prophylaxis of AIDS-associated cryptococcosis: a case controlled study. Scand. J. Infect. Dis, 27, 235, 1995.PubMedCrossRefGoogle Scholar
  96. 96.
    Nelson, M. R., Fisher, M., Cartledge, J., Rogers, T., and Gazzard, B. G. The role of azoles in the treatment and prophylaxis of cryptococcal disease in HIV infection. AIDS, 8, 651, 1994 [see also: AIDS, 9, 300, 1995 ].Google Scholar
  97. 97.
    Manfredi, R., Mastroianni, A., Coronado, O. V., and Chiodo, F. Fluconazole as prophylaxis against fungal infection in patients with advanced HIV infection. Arch. Intern. Med, 157, 64, 1997PubMedCrossRefGoogle Scholar
  98. 98.
    Georgiev, V. St. Opportunistic/nosocomial infections: treatment and developmental therapeutics. I. Cryptococcosis. Med. Res. Rev, 13, 493–506, 1993.CrossRefGoogle Scholar
  99. 99.
    Fernandez-Concepcion, O., Ariosa-Acuna, M. C., Giroud-Benitez, J. L., Pando-Cabrera, A., Garcia-Fidalgo, J A., and MestreMiguelez, R. Cryptococcosis of the central nervous system. A report of five cases. Rev. Neurol, 30, 935–938, 2000.PubMedGoogle Scholar
  100. 100.
    Emmons, C. W., Binford, C. H., and Utz, J. P. Medical Mycology, 2nd ed. Lea Fabiger, Philadelphia, 190, 1970.Google Scholar
  101. 101.
    Zuger, A., Schuster, M., Simberkoff, M. S., Rahal, J. J., and Holzman, R. S. Maintenance amphotericin B for cryptococcal meningitis in the acquired immunodeficiency syndrome (AIDS). Ann. Intern. Med, 109, 592, 1988.PubMedGoogle Scholar
  102. 102.
    Holmberg, K. and Meyer, R. D. Fungal infections in patients with AIDS and AIDS-related complex. Scand. J. Infect. Dis, 18, 179, 1986.PubMedCrossRefGoogle Scholar
  103. 103.
    Chechani, V. and Kamholz, S. L. Optimal therapy of cryptococcosis in patients with the acquired immunodeficiency syndrome. NY State J. Med, 91, 292, 1991.Google Scholar
  104. 104.
    de Lalla, F., Pellizzer, G., Vaglia, A., et al., Amphotericin B as primary therapy for cryptococcosis in patients with AIDS: reliability of relatively high doses administered over a relatively short period. Clin. Infect. Dis, 20, 263, 1995.PubMedCrossRefGoogle Scholar
  105. 105.
    Churchill, D. and Coker, R. Amphotericin B as primary therapy for cryptococcosis in patients with AIDS: reliability of relatively high doses over a relatively short period. Clin. Infect. Dis, 21, 1352, 1995.PubMedCrossRefGoogle Scholar
  106. 106.
    de Lalla, F., Pellizzer, G., Vaglia, A., et al. Amphotericin B as primary therapy for cryptococcosis in patients with AIDS: reliability of relatively high doses over a relatively short period: a reply. Clin. Infect. Dis, 21, 1353, 1995.CrossRefGoogle Scholar
  107. 107.
    Diamond, R. D. and Bennett, J. E. A subcutaneous reservoir for intrathecal therapy of fungal meningitis. N. Engl. J. Med, 288, 186, 1973.PubMedCrossRefGoogle Scholar
  108. 108.
    Polsky, B., Depman, M. R., Gold, J. W. M., Galicich, J. H., and Armstrong, D. Intraventricular therapy of cryptococcal meningitis via a subcutaneous reservoir. Am. J. Med, 81, 24, 1986.PubMedCrossRefGoogle Scholar
  109. 109.
    Roberts, N. J. and Douglas, R. G. Cryptococcal meningitis: cure despite cryptococcemia. Arch. Neurol, 35, 179, 1978.PubMedCrossRefGoogle Scholar
  110. 110.
    Sapico, F. L. Disappearance of focal cryptococcal brain lesion on chemotherapy alone. Lancet, 1, 560, 1979.PubMedCrossRefGoogle Scholar
  111. 111.
    Bastin, R., Vildé, J. L., Drouhet, E., and Carbon, C. Primary meningitis due to Cryptococcus neoformans associated with polyradiculitis: cure by amphotericin B. Sem. Hop. Paris, 50, 337, 1974.PubMedGoogle Scholar
  112. 112.
    Sugar, A. M., Stern, J. J., and Dupont, B. Overview: treatment of cryptococcal meningitis. Rev. Infect. Dis, 12 (Suppl 3), 5338, 1990.CrossRefGoogle Scholar
  113. 113.
    Hay, R. J. Use of ambisome, liposomal amphotericin B in systemic fungal infections: preliminary findings of a European multicenter study, in Recent Progress in Antifungal Chemotherapy, Yamaguchi, H., Kobayashi, G. S., and Takeuchi, H., Eds. Marcel Dekker, New York, 323, 1992.Google Scholar
  114. 114.
    Coker, R., Tomlinson, D., and Harris, J. Successful treatment of cryptococcal meningitis with liposomal amphotericin B after failure of treatment with fluconazole and conventional amphotericin B. AIDS, 5, 231, 1991.Google Scholar
  115. 115.
    Schurmann, D., de Matos Marques, B., Grunwald, T., Pohle, H. D., Hahn, H., and Ruf, B. Safety and efficacy of liposomal amphotericin B in treating AIDS-associated disseminated cryptococcosis. J. Infect. Dis, 164, 620, 1991.PubMedCrossRefGoogle Scholar
  116. 116.
    Ikemoto, H., Yashiro, M., Furugori, T., and Kudo, Y. Unusual treatment of cryptococcal meningitis successfully treated with a small amount of amphotericin B, a large amount of prednisolone, and continued removal of cerebrospinal fluid. J. Antibiot, 20, 374, 1967.PubMedGoogle Scholar
  117. 117.
    Yashiro, M., Furugori, T., Kudo, Y., and Ikemoto, H. Cryptococcal meningitis successfully treated with amphotericin B, adrenal corticosteroid, and continuous removal of the cerebrospinal fluid. Naika, 20, 1155, 1967.PubMedGoogle Scholar
  118. 118.
    Brisman, R., Reid, R., and Harrington, G. Intracranial cryptococcal granuloma - amphotericin B and surgical excision. Surg. Neurol, 1, 43, 1973.PubMedGoogle Scholar
  119. 119.
    Dillon, M. C. and Sealy, W. C. Surgical aspects of opportunistic fungus infection. Lab. Invest, 11, 1231, 1962.Google Scholar
  120. 120.
    Reeves, D. C. Cryptococcic (Torula) granuloma of the scull. J. Neurol, 27, 70, 1967.Google Scholar
  121. 121.
    Rish, B. L. and Meacham, W. F. Intracerebral cystic toruloma. J. Neurosurg, 28, 603, 1968.PubMedCrossRefGoogle Scholar
  122. 122.
    Vijayan, N., Bhatt, G. P., and Dreyfus, P. M. Intraventricular cryptococcal granuloma. Neurology, 21, 728, 1971.PubMedCrossRefGoogle Scholar
  123. 123.
    Einstein, H. E., Brown, J. F., and Holmes, C. W. Some treatment aspects of coccidioidal meningitis, in Progress Report of the VA-Armed Forces Coccidioidomycosis Study Group No 7, Salkin, D. and Huppert, M., Eds. California VA Hospital, San Francisco, 17, 1969.Google Scholar
  124. 124.
    Pappagianis, D. Meningitis in children, in Progress Report of the VA- Armed Forces Coccidioidomycosis Study Group No 8, Salkin, D. and Hupper, M., Eds. California VA Hospital, San Francisco, 16, 1969.Google Scholar
  125. 125.
    Schonheyder, H., Thestrup-Pedersen, K., Esmann, V., and Stenderup, A. Cryptococcal meningitis: complications due to intrathecal treatment. J. Infect. Dis, 12, 155, 1980.Google Scholar
  126. 126.
    Swenson, R. S., Kountz, S. L., Blank, N., and Merigan, T. C. Successful renal allograft in a patient with pulmonary cryptococcosis. Arch. Intern. Med, 124, 502, 1969.PubMedCrossRefGoogle Scholar
  127. 127.
    Oka, S., Sugimoto, H., and Shimada, K. Problems in the treatment of fungal infections after renal transplantation in Japan, in Recent Progress in Antifungal Chemotherapy, Yamaguchi, H., Kobayashi, G. S., and Takeuchi, H., Eds. Marcel Dekker, New York, 239, 1992.Google Scholar
  128. 128.
    Shindo, K. Treatment of cryptococcal meningitis with five antifungal drugs: the role of amphotericin B. Drugs Exp. Clin. Res, 16, 327, 1991.Google Scholar
  129. 129.
    Liu, Y. C., Cheng, D. L., Liu, C. Y., Yen, M. Y., and Wang, R. S. Isolated cryptococcosis of the adrenal gland. J. Intern. Med, 230, 285, 1991.PubMedCrossRefGoogle Scholar
  130. 130.
    Perkins, W. Pulmonary cryptococcosis: report on the treatment of nine cases. Dis. Chest, 56, 398, 1969.CrossRefGoogle Scholar
  131. 131.
    Lopez-Berestein, G., Fainstein, V., Hersh, E. M., et al. Treatment of disseminated fungal infections in mammals with liposome-encapsulated amphotericin B. U.S. Patent 4, 663, 167, 1987.Google Scholar
  132. 132.
    Fajardo, L. F. Failure of topical amphotericin B in cryptococcosis. Ann. Intern. Med, 78, 777, 1973.Google Scholar
  133. 133.
    Kojima, T., Matsuzaki, M., Sano, M., et al. Acute lymphocytic leukemia, complicated with generalized cryptococcosis successfully treated by amphotericin B: a case report. Rinsho Ketsueki, 26, 217, 1985.PubMedGoogle Scholar
  134. 134.
    Lerner, P. I. and Weinstein, L. Infective endocarditis in the antibiotic era. N. Engl. J. Med, 274, 388, 1966.PubMedCrossRefGoogle Scholar
  135. 135.
    Lombardo, T. A., Rabson, A. D., and Dodge, H. T. Mycotic endocarditis: report of a case due to Cryptococcus neoformans. Am. J. Med, 22, 664, 1957.CrossRefGoogle Scholar
  136. 136.
    Miller, R. P. and Bates, J. H. Amphotericin B toxicity: a follow-up report of 53 patients. Ann. Intern. Med, 71, 1089, 1969.PubMedGoogle Scholar
  137. 137.
    Ellincy, B. R. Amphotericin B usage in pregnancy complicated by cryptococcosis. Am. J. Obstet. Gynecol, 115, 285, 1973.Google Scholar
  138. 138.
    Silberfarb, P. M., Sarosi, G. A., and Tosh, F. E. Cryptococcosis and pregnancy. Am. J. Obstet. Gynecol, 112, 714, 1972.PubMedGoogle Scholar
  139. 139.
    Li, P. K. and Lai, K. N. Amphotericin B induced ocular toxicity in cryptococcal meningitis. Br. J. Ophthalmol, 73, 397, 1989.PubMedCrossRefGoogle Scholar
  140. 140.
    Kaminaga, Y., Shindo, K., Ito, A., and Iizuma, H. Mycological and clinical study of cryptococcosis in Yokohama City University Hospital during the period from 1965 to 1989. Kansenshogaku Zasshi, 65, 374, 1991.PubMedGoogle Scholar
  141. 141.
    Armstrong, D. Treatment of fungal infections in the immunocompromised host, in Recent Progress in Antifungal Chemotherapy, Yamaguchi, H., Kobayashi, S. G., and Takeuchi, H., Eds. Marcel Dekker, New York, 251, 1992.Google Scholar
  142. 142.
    Hackett, A. J., Sylvester, S. S., Joss, U. R., and Calvin, M. Synergistic effect of rifamycin derivatives and amphotericin B on viral transformation of a murine cell line. Proc. Natl. Acad. Sci. USA, 69, 3653, 1972.PubMedCrossRefGoogle Scholar
  143. 143.
    Kuwano, M., Akiyama, S., Endo, H., and Kohga, M. Potentiation of fusidic acid and lentinan effects upon normal and transformed fibroblastic cells by amphotericin B. Biochem. Biophys. Res. Commun, 49, 1241, 1972.PubMedCrossRefGoogle Scholar
  144. 144.
    Medoff, G. and Kobayashi, G. S. Amphotericin B and 5-fluorocytosine. J. Infect. Dis, 132, 489, 1975.PubMedCrossRefGoogle Scholar
  145. 145.
    Jimbow, T., Tejima, Y., and Ikemoto, H. Comparison between 5-fluorocytosine, amphotericin B and the combined administration of these agents in the therapeutic effectiveness for cryptococcal meningitis. Chemotherapy, 24, 374, 1978.PubMedCrossRefGoogle Scholar
  146. 146.
    Bennett, J. E., Dismukes, W. E., Duma, R. J., et al. A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptococcal meningitis. N. Engl. J. Med, 301, 127, 1979.CrossRefGoogle Scholar
  147. 147.
    MacGregor, R. R. Treatment of cryptococcal meningitis. N. Engl. J. Med, 318, 380, 1988.CrossRefGoogle Scholar
  148. 148.
    Schmutzhard, E. and Vejajjiva, A. Treatment of cryptococcal meningitis with high-dose, long-term combination amphotericin B and flucytosine. Am. J. Med, 85, 737, 1988.PubMedCrossRefGoogle Scholar
  149. 149.
    Sahai, J. Management of cryptococcal meningitis in patients with AIDS. Clin. Pharmacy, 7, 528, 1988.Google Scholar
  150. 150.
    Kauffman, C. A. and Frame, P. T. Bone marrow toxicity associated with 5-fluorocytosine therapy. Antimicrob. Agents Chemother, 11, 244, 1977.PubMedCrossRefGoogle Scholar
  151. 151.
    Donahue, R. E., Johnson, M. M., Zon, L. I., Clark, S. C., and Groopman, J. E. Suppression of in vitro haematopoiesis following human immunodeficiency virus infection. Nature, 326, 200, 1987.Google Scholar
  152. 152.
    Kotler, D. P., Gaetz, H. P., Lange, M., Klein, E. B., and Holt, P. R. Enteropathy associated with acquired immunodeficiency syndrome. Ann. Intern. Med, 101, 421, 1984.PubMedGoogle Scholar
  153. 153.
    Chuck, S. L. and Sande, M. A. Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome. N. Engl. J. Med, 321, 794, 1989.PubMedCrossRefGoogle Scholar
  154. 154.
    Dismukes, W. E. Treatment of systemic fungal diseases in patients with AIDS, in Recent Progress in Antifungal Chemotherapy, Yamaguchi, H., Kobayashi, G. S., and Takeuchi, H., Eds. Marcel Dekker, New York, 227, 1992.Google Scholar
  155. 155.
    Bayardelle, P., Giard, N., Maltais, R., Delorme, J., and Brazean, M. Success with amphotericin B and 5-fluorocytosine in treating cerebral cryptococcoma accompanying cryptococcal meningitis. Can. Med. Assoc. J, 127, 732, 1982.PubMedGoogle Scholar
  156. 156.
    Koeleman, J. G., Rustemejer, C., Wijermans, P. W., and MacLaren, D. M. Cryptococcal meningo-encephalitis after prolonged corticosteroid therapy. Neth. J. Med, 36, 242, 1990.Google Scholar
  157. 157.
    Carney, M. D., Combs, J. L., and Waschler, W. Cryptococcal choroiditis. Retina, 10, 27, 1990.PubMedCrossRefGoogle Scholar
  158. 158.
    Picon, L., Vaillant, L., Duong, T., et al. Cutaneous cryptococcosis resembling molluscum contagiosum: a first manifestation of AIDS. Acta Derm. Venereo!. (Stockholm), 69, 365, 1989.Google Scholar
  159. 159.
    Tobias, J. S., Wrigley, P. F. M., and Shaw, E. Combination antifungal therapy for cryptococcal meningitis. Postgrad. Med. J, 52, 305, 1976.PubMedCrossRefGoogle Scholar
  160. 160.
    Watson, A. J, Russell, R. P., Cabreja, R. F., Braverman, R., and Whelton, A. Cure of cryptococcal infection during continued immunosuppressive therapy. Q. J. Med, 55, 169, 1985.Google Scholar
  161. 161.
    Gallis, H. A., Berman, R. A., Cate, T. R., Hamilton, J. D., Gunnels, J.C., and Stickel, D. L. Fungal infection following renal transplantation. Arch. Intern. Med, 135, 1163, 1975.PubMedCrossRefGoogle Scholar
  162. 162.
    Mills, S. A., Seigler, H. F., and Wolfe, W. G. The incidence and management of pulmonary mycosis in renal allograft patients. Ann. Surg, 182, 617, 1975.PubMedCrossRefGoogle Scholar
  163. 163.
    Kong, N. C., Sharriah, W., Morad, Z., Suleiman, A. B., and Wong, Y. H. Cryptococcosis in a renal unit. Aust. N. Z. J. Med, 20, 645, 1990.PubMedCrossRefGoogle Scholar
  164. 164.
    Kimura, K., Hatekayama, M., Miyagi, J., et al. A case of systemic lupus erythematosus with cryptococcal meningitis successfully treated with amphotericin B and 5-FC. Nipon Naika Gakkai Zasshi, 75, 406, 1986.CrossRefGoogle Scholar
  165. 165.
    Butler, W. P. and Kaufer, G. I. Primary cutaneous cryptococcosis successfully treated with outpatient amphotericin B and 5-fluorocytosine. Nita, 8, 295, 1985.PubMedGoogle Scholar
  166. 166.
    Woolfitt, R., Park, H. M., and Greene, M. Localized cryptococcal osteomyelitis. Radiology, 120, 290, 1976.PubMedGoogle Scholar
  167. 167.
    Nottebart, H. C., McGehee, R. F., and Utz, J. P. Cryptococcus neoformans osteomyelitis: case report of two patients. Sabouraudia, 12, 127, 1974.PubMedCrossRefGoogle Scholar
  168. 168.
    Chand, K. and Lan, K. S. Cryptococcosis of the knee joint. Acta Orthop. Scand, 47, 432, 1976.PubMedCrossRefGoogle Scholar
  169. 169.
    Nathan, C. F. Cryptococcal osteomyelitis treated with 5-fluorocytosine. Am. Rev. Respir. Dis, 110, 78, 1974.Google Scholar
  170. 170.
    Luhr, H. and Svane, S. Pulmonary pseudomotor caused by Cryptococcus neoformans. Tidsskr. Nor. Laegeforen, 111, 3288, 1991.Google Scholar
  171. 171.
    Schmidt-Westhausen, A., Grunewald, T., Reihart, P. A., and Pohle, H. D. Oral cryptococcosis in a patient with AIDS: a case report. Oral. Dis, 1, 77, 1995 [see also: Oral Dis, 1, 61, 1995 ].Google Scholar
  172. 172.
    Iida, Y., Maehara, K., Okamoto, Y., et al. A case of cryptococcal meningitis treated by ketoconazole and amphotericin B combination therapy. Kansenshogaku Zasshi, 60, 189, 1986.PubMedGoogle Scholar
  173. 173.
    Echevarria, A., Pinzon, V., Toro, J., and Diaz Issacs, M. Pulmonary cryptococcosis. Rev. Med. Panama, 16, 50, 1991.Google Scholar
  174. 174.
    Aslam, P. A., Larkin, J., Eastridge, C. E., and Hughes, F. A. Endocavitary infusion through percutaneous endobronchial catheter. Chest, 57, 94, 1970.PubMedCrossRefGoogle Scholar
  175. 175.
    Stamm, A. M., Diasio, R. B., Dismukes, W. E., et al. Toxicity of amphotericin B plus flucytosine in 194 patients with cryptococcal meningitis. Am. J. Med, 83, 236, 1987.PubMedCrossRefGoogle Scholar
  176. 176.
    Shindo, K., Mizuno, T., Matsumoto, Y., et al. Granulocytopenia and thrombocytopenia associated with combination therapy of amphotericin B and low-dose flucytosine in a patient with cryptococcal meningitis. DICP, 23, 672, 1989.Google Scholar
  177. 177.
    Bryan, C. S. and McFarland, J. A. Cryptococcal meningitis: fatal marrow applasia from combined therapy. J. Am. Med. Assoc., 239, 1068, 1978.CrossRefGoogle Scholar
  178. 178.
    Tassel, D. and Madoff, M. A., Treatment of Candida sepsis and Cryptococcus meningitis with 5-fluorocytosine: a new antifungal agent. J. Am. Med. Assoc, 260, 830, 1968.CrossRefGoogle Scholar
  179. 179.
    Sanati, H., Messer, S. A., Pfaller, M., et al. Multicenter evaluation of broth microdilution method for susceptibility testing of Cryptococcus neoformans against fluconazole. J. Clin. Microbiol, 34, 1280, 1996.PubMedGoogle Scholar
  180. 180.
    Koechlin, B. A., Rubio, S., Palmer, S., Gabriel, T., and Duschinsky, R. The metabolism of 5-fluorocytosine-2[14C] and cytosine[14C] in the rat and the disposition of 5-fluorocytosine- 2[14C] in man. Biochem. Pharmacol, 15, 435, 1966.PubMedCrossRefGoogle Scholar
  181. 181.
    Shadomy, S. Further in vitro studies with 5-fluorocytosine. Infect. Immun, 2, 484, 1970.PubMedGoogle Scholar
  182. 182.
    Roberts, M., Rinaudo, P. A., Tilton, R. C., and Vilinskas, J. Treatment of multiple intracerebral cryptococcal granulomas with 5-fluorocytosine. J. Neurosurg, 37, 229, 1972.PubMedCrossRefGoogle Scholar
  183. 183.
    Editorial. Cryptococcosis and 5-fluorocytosine. Aust. N. Z. J. Med, 4, 296, 1974.CrossRefGoogle Scholar
  184. 184.
    Sabetta, J. R. and Andriole, V. T. Cryptococcal infections in the central nervous system. Med. Clin. North Am, 69, 334, 1985.Google Scholar
  185. 185.
    Block, E. R. and Bennett, J. E. Clinical and pharmacological studies with 5-fluorocytosine (5-FC). Clin. Res, 20, 525, 1972.Google Scholar
  186. 186.
    Utz, J. P., Shadomy, S., McGehee, R. F., and Tynes, B. S. 5-Fluorocytosine: experience in patients with pulmonary and other forms of cryptococcosis. Am. Rev. Respir. Dis, 99, 975, 1969.Google Scholar
  187. 187.
    Zylstra, W. Cryptococcosis and 5-fluorocytosine: comment. Aust. N. Z. J. Med, 4, 296, 1974.PubMedCrossRefGoogle Scholar
  188. 188.
    Vandevelle, A. G., Nauceri, A. A., and Johnson III, J. E. 5-Fluorocytosine in the treatment of mycotic infections. Ann. Intern. Med, 77, 43, 1972.Google Scholar
  189. 189.
    Fass, R. J. and Perkins, R. L. 5-Fluorocytosine in the treatment of cryptococcal and Candida mycoses. Ann. Intern. Med, 74, 535, 1971.PubMedGoogle Scholar
  190. 190.
    Schlegel, R. J., Bernier, G. M., Bellanti, J. A., et al. Severe candidiasis asociated with thymic displasia, IgA deficiency and plasma antilymphocyte effects. Pediatrics, 45, 926, 1970.Google Scholar
  191. 191.
    McDonnell, F. I., Clunie, G. J. A., Petrie, J. J. G., and Rao, A. Experience with 5- fluorocytosine in a dialysis-transplant unit. Aust. N. Z. J. Med, 3, 438, 1973.Google Scholar
  192. 192.
    Kauffman, C. A. and Frame, P. T. Bone marrow toxicity associated with 5-fluorocytosine therapy. Antimicrob. Agents Chemother, 11, 244, 1977.PubMedCrossRefGoogle Scholar
  193. 193.
    Bryan, C. S. and McFarland, J. A. Cryptococcal meningitis: fatal marrow aplasia from combined therapy. J. Am. Med. Assoc, 239, 1068, 1978.CrossRefGoogle Scholar
  194. 194.
    Philpot, C. R. and Lo, D. Cryptococcal meningitis in pregnancy. Med. J. Aust, 2, 1005, 1972.PubMedGoogle Scholar
  195. 195.
    Deresinski, S. C., Lilly, R. B., Levine, H. B., Galgiani, J. N., and Stevens, D. A. Treatment of fungal meningitis with miconazole. Arch. Intern. Med, 137, 1180, 1977.PubMedCrossRefGoogle Scholar
  196. 196.
    Ito, A., Therapeutic results with miconazole in Japan, in Recent Progress in Antifungal Chemotherapy, Yamaguchi, H., Kobayashi, G. S., and Takeuchi, H., Eds. Marcel Dekker, New York, 183, 1991.Google Scholar
  197. 197.
    Sung, J. P., Grendale, J. G., and Levine, H. B., Intravenous and intrathecal miconazole therapy for systemic mycosis. West. J. Med, 126, 5, 1977.PubMedGoogle Scholar
  198. 198.
    Weinstein, L. and Jacoby, I., Successful treatment of cerebral cryptococcoma and meningitis with miconazole. Ann. Intern. Med, 93, 569, 1980.PubMedGoogle Scholar
  199. 199.
    Belle, W. E., Treatment of fungal infections of the central nervous system. Ann. Neurol, 9, 417, 1981.CrossRefGoogle Scholar
  200. 200.
    Sung, J. P., Campbell, G. D., and Grendahl, J. C., Miconazole therapy for fungal meningitis. Arch. Neurol, 35, 443, 1978.PubMedCrossRefGoogle Scholar
  201. 201.
    Perfect, J. R., Durack, D. T., Hamilton, J. D., and Gallis, H. A., Failure of ketoconazole in cryptococcal meningitis. J. Am. Med. Assoc, 247, 3349, 1982.CrossRefGoogle Scholar
  202. 202.
    Ogushi, F., Tamura, M., Ozaki, T., et al. A case of cryptococcal meningitis improved in the treatment of high dose ketoconazole. Kansenshogaku Zasshi, 59, 405, 1985.PubMedGoogle Scholar
  203. 203.
    Karaffa, C. A., Rehm, S. J., and Keys, T. F. The acquired immunodeficiency syndrome and cryptococcosis. Ann. Intern. Med, 104, 891, 1986.PubMedGoogle Scholar
  204. 204.
    Granier, F., Kamitakis, J., Hermier, C., Zhu, Y. Y., and Thivolet, J. Localized cutaneous cryptococcosis successfully treated with ketoconazole. J. Am. Acad. Dermatol, 16, 243, 1987.PubMedCrossRefGoogle Scholar
  205. 205.
    Bernard, E., Caries, M., Toussaint-Gari, M., Fournier, J. P., and Dellamonica, P. Value of fluconazole in the treatment of systemic yeast infection. Pathol. Biol. (Paris), 37, 690, 1989.Google Scholar
  206. 206.
    Shuttleworth, D., Philpot, C. M., and Knight, A. G. Cutaneous cryptococcosis: treatment with oral fluconazole. Br. J. Dermatol, 120, 683, 1989.PubMedCrossRefGoogle Scholar
  207. 207.
    Nakashima, M. The clinical study of fluconazole against pulmonary cryptococcosis and aspergillosis, and its pharmacokinetics in patients. Jpn. J. Antibiot, 42, 127, 1989.PubMedCrossRefGoogle Scholar
  208. 208.
    Mares, M., Sartori, M. T., Carretta, M., Bertaggia, A., and Girolami, A. Rhinophyma-like cryptococcal infection as an early manifestation of AIDS in a hemophilia B patient. Acta Haematol, 84, 101, 1990.PubMedCrossRefGoogle Scholar
  209. 209.
    Zalcman, G., Lechapt, E., Milleron, B., Denis, M., Mayaud, C., and Akoun, G. Pleuropulmonary cryptococcosis disclosing AIDS. Rev. Pneumol. Clin, 47, 133, 1991.PubMedGoogle Scholar
  210. 210.
    Bozzette, S. A., Larsen, R. A., Chiu, J., et al. Fluconazole treatment of persistent Cryptococcus neoformans prostatic infection in AIDS. Ann. Intern. Med, 115, 285, 1991.PubMedGoogle Scholar
  211. 211.
    Sugar, A. M. Overview: cryptococcosis in the treatment of AIDS. Mycopathologia, 114, 153, 1991.PubMedCrossRefGoogle Scholar
  212. 212.
    Levesque, H., Alie-Legrand, M. C., Omnient, Y., et al. Cryptococcus neoformans meningitis and cirrhosis: value of fluconazole. Clin. Biol., 13, 942, 1989.Google Scholar
  213. 213.
    Michelone, G., Tacconi, F., Maccabruni, A., Lanzarini, P., Tinelli, M., and Dei Cas, A. Clinical and therapeutic profile of 3 cases of cryptococcal meningitis in patients with AIDS. G. Ital. Chemoter, 36, 95, 1989.Google Scholar
  214. 214.
    Krisch, H. and Sarnow, E. Collection of cases in relation to clinical trials of fluconazole in Germany. Mycoses, 33 (Suppl. 1), 145, 1990.Google Scholar
  215. 215.
    Reents, S. B. and Powell, G. Fluconazole success after amphotericin B and flucytosine failure in cryptococcal meningitis. DICP, 24, 885, 1990.Google Scholar
  216. 216.
    Lindberg, J. and Edebo, L. Successful treatment of cryptococcal meningitis with fluconazole. Lakartidningen, 88, 2245, 1991.PubMedGoogle Scholar
  217. 217.
    Good, C. B. and Leeper, H. F. Profound papilledema due to cryptococcal meningitis in acquired immunodeficiency syndrome: successful treatment with fluconazole. South. Med. J, 84, 394, 1991.PubMedCrossRefGoogle Scholar
  218. 218.
    Dismukes, W. E. Treatment of systemic fungal diseases in patients with AIDS, in Recent Progress in Antifungal Chemotherapy, Yamaguchi, H., Kobayashi, G. S., and Takahashi, H., Eds. Marcel Dekker, New York, 227, 1992.Google Scholar
  219. 219.
    Jones, P. D., Marriott, D., and Speed, B. R. Efficacy of fluconazole in cryptoccocal meningitis. Diagn. Microbiol. Infect. Dis, 12 (Suppl. 4), 235S, 1989.PubMedCrossRefGoogle Scholar
  220. 220.
    Dupont, B. Treatment of cryptococcal meningitis, in Proc. Xth Congr. Int. Soc. Human Animal Mycol., Barcelona, Torres-Rodriguez, J. M., Ed. J. R. Prous, 197, 1988.Google Scholar
  221. 221.
    Byrne, W. R. and Wajszczuk, C. P. Cryptococcal meningitis in the acquired immunodeficiency syndrome (AIDS): successful treatment with fluconazole after failure of amphotericin B. Ann. Intern. Med, 108, 384, 1988.PubMedGoogle Scholar
  222. 222.
    Dromer, F., Mathoulin, S., Dupont, B., Brugiere, O., and Letenneur, L., Comparison of the efficacy of amphotericin B and fluconazole in the treatment of cryptococcosis in human immunodeficiency virus-negative patients: retrospective analysis of 83 cases. Clin. Infect. Dis, 22 (Suppl. 2), 5154, 1996.CrossRefGoogle Scholar
  223. 223.
    Larsen, R. A., Leal, M. A., and Chan, L. S., Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS: a randomized trial. Ann. Intern. Med, 113, 183, 1990.PubMedGoogle Scholar
  224. 224.
    Wong, R. D. and Goetz, M. B., Treatment of cryptococcal meningitis in AIDS. J. Infect. Dis, 113, 992, 1990.Google Scholar
  225. 225.
    Buxton, M. J., Dubois, D. J., Turner, R. R., Sculpher, M. J., Robinson, P. A., and Searcy, C., Cost implications of alternative treatments for AIDS patients with cryptococcal meningitis: comparison of fluconazole and amphotericinbased therapies. J. Infect, 23, 17, 1991.PubMedCrossRefGoogle Scholar
  226. 226.
    Bolignano, G., Chindemi, G., and Criseo, G., Cryptococcal meningoencephalitis in a patient with Hodgkin’s lymphoma: successful treatment with fluconazole. Mycoses, 34, 63, 1991.PubMedCrossRefGoogle Scholar
  227. 227.
    Iacopino, P., Morabito, F., Martino, B., Bolignano, G., and Nobile, F., Fluconazole for disseminated cryptococcosis in a patient with Hodgkin’s disease. Haematologica, 76, 260, 1991.PubMedGoogle Scholar
  228. 228.
    Sugar, A. M. and Saunders, C. Oral fluconazole as suppressive therapy of disseminated cryptococcosis in patients with acquired immunodeficiency syndrome. Am. J. Med, 85, 481, 1988.CrossRefGoogle Scholar
  229. 229.
    Bozzette, S. A., Larsen, R. A., Chiu, J., et al. A placebo-controlled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome. N. Engl. J. Med, 324, 580, 1991.PubMedCrossRefGoogle Scholar
  230. 230.
    Powderly, W., Saag, M., Cloud, G., et al., Fluconazole versus amphotericin B as maintenance therapy for prevention of relapse of AIDS-associated cryptococcal meningitis. 30th Intersci. Conf. Antimicrob. Agents Chemother. American Society for Microbiology, Washington, DC, abstract 1162, 1990.Google Scholar
  231. 231.
    Laroche, R., Deppner, M., Floch, J. J., et al. Cryptococcosis in Bujumbura, Burundi: apropos of 80 observed cases in 42 months. Bull. Soc. Pathol. Exot. Fil, 83, 159, 1990.Google Scholar
  232. 232.
    Stern, J. J., Hartman, B. J., Sharkey, K., et al. Oral fluconazole therapy for patients with acquired immunodeficiency syndrome and cryptococcosis: experience with 22 patients. Am. J. Med, 85, 477, 1988.PubMedCrossRefGoogle Scholar
  233. 233.
    Sort, P., Morales, M., Gomez, J., Pares, A., and Rodes, J. Pleural empyema caussed by Cryptococcus neoformans in a patient with liver cirrhosis. Gastroenterol. Hepatol, 19, 302, 1996.PubMedGoogle Scholar
  234. 234.
    Agarwal, A., Gupta, A., Sakhuja, V., Talwar, P., Joshi, K., and Chugh, K. S. Retinitis following disseminatedGoogle Scholar
  235. cryptococcosis in a renal allograft recipient: efficacy of oral fluconazole. Acta Ophthalmol (Copenhagen), 69, 402, 1991.Google Scholar
  236. 235.
    Custis, P. H., Haller, J. A., and de Juan, E. Jr. An unusual case of cryptococcal endophthalmitis. Reina, 15, 300, 1995.Google Scholar
  237. 236.
    Vandersmissen, G., Meuleman, L., Tits, G., Verhaeghe, A., and Peetermans, W. E. Cutaneous cryptococcosis in corticosteroid-treated patients without AIDS. Acta Clin. Belg, 51, 111, 1996.PubMedGoogle Scholar
  238. 237.
    Halweg, H., Korzeniewska-Kosela, M., Podsiadlo, B., and Krakowka, P. A case of skin cryptococcosis in systemic lupus erythematosus. Pneumonol. Pol., 58, 544, 1990.Google Scholar
  239. 238.
    Pineski, R., Mathurin, S. A., Ruffinengo, O., Alonso, H. O., and Corallini de Bracelenti, B. Cutaneous cryptococcosis in a patient receiving chronic immunosuppressive therapy. Cutis, 57, 229, 1996.PubMedGoogle Scholar
  240. 239.
    Verneuil, L., Dompmartin, A., Duhamel, C., et al. Cryptococcal whitlow in a HIV-positive patient. Ann. Dermatol. Venereal, 122, 688, 1995.Google Scholar
  241. 240.
    Kerchner, J. E., Ridley, M. B., and Greene, J. N. Laryngeal Cryptococcus: treatment with oral fluconazole. Arch. Otolaryngol. Head Neck Surg, 121, 1193, 1995.CrossRefGoogle Scholar
  242. 241.
    Schmidt, D. M., Sercarz, J. A., Kevorkian, K. F., and Canalis, R. F. Cryptococcus presenting as a neck mass. Ann. Otol. Rhinol. Laryngol, 104, 711, 1995.PubMedGoogle Scholar
  243. 242.
    Yew, W. W., Wong, P. C., Wong, C. F., Lee, J., and Chau, C. H. Oral fluconazole in the treatment of pulmonary cryptococcosis in non-AIDS patients. Drugs Exp. Clin. Res, 22, 25, 1996.PubMedGoogle Scholar
  244. 243.
    Feczko, J. M. Overview of fluconazole in Recent Progress in Antifungal Chemotherapy, Yamaguchi, H., Kobayashi, G. S., and Takahashi, H., Eds. Marcel Dekker, New York, 191, 1992.Google Scholar
  245. 244.
    Troke, P. F., Marriott, M. S., Richardson, K., and Tarbit, M. H. In vitro potency and in vivo activity of azoles. Ann. NY Acad. Sci, 544, 284, 1988.Google Scholar
  246. 245.
    Guillaume, M. P., De Prez, C., and Cogan, E. Subacute mitochondroal liver disease in a patient with AIDS: possible relationship to prolonged fluconazole administration. Am. J. Gastroenterol, 91, 165, 1996.PubMedGoogle Scholar
  247. 246.
    Pappas, P. G., Kauffman, C. A., Perfect, J., et al. Alopecia associated with fluconazole therapy. Ann. Intern. Med, 123, 354, 1995 [see comment in Ann. Intern. Med, 125, 153, 1996 ].Google Scholar
  248. 247.
    Weinroth, S. E., and Tuazon, C. U. Alopecia associated with fluconazole treatment. Ann. Intern. Med, 119, 637, 1993.PubMedGoogle Scholar
  249. 248.
    Coker, R. J. and Harris, J. R. Failure of fluconazole treatment in cryptococcal meningitis despite adequate CSF levels. J. Infect, 123, 101, 1991.CrossRefGoogle Scholar
  250. 249.
    Bailly, M. P., Boibieux, A., Biron, F., et al. Persistence of Cryptococcus neoformans in prostate: failure of fluconazole despite high doses. J. Infect. Dis, 164, 435, 1991.PubMedCrossRefGoogle Scholar
  251. 250.
    Pietroski, N., Buckley, R. M., Braffman, M. N., and Stern, J. J. Intravenous and oral fluconazole in treatment of acute cryptococcal meningitis in AIDS. 30th Intersci. Conf. Antimicrob. Agents Chemother, American Society for Microbiology, Washington, DC, abstract 576, 1990.Google Scholar
  252. 251.
    Squires, K., Rowland, V., Gassyuk, E., et al. Fluconazole as therapy for acute cryptococcal meningitis. 30th Intersci. Conf. Antimicrob. Agents Chemother, American Society for Microbiology, Washington, DC, abstract 573, 1990.Google Scholar
  253. 252.
    Aller, A. I., Martin-Mazuelos, E., Lozano, F., et al. Correlation of fluconazole MICs with clinical outcome in cryptococcal infection. Antimicrob. Agents Chemother, 44, 1544–1548, 2000.Google Scholar
  254. 253.
    Orni-Wasserlauf, R., Siegman-Igra, Y., Izkhakov, E., Bash, E., Polacheck, I., and Giladi, M. Fluconazole-resistant Cryptococcus neoformans isolated from an immunocompetent patient without prior exposure to fluconazole. 38th Intersci. Conf. Antimicrob. Agents Chemother, American Society of Microbiology, Washington, DC, 458, abstract J24, 1998.Google Scholar
  255. 254.
    Abi-Hanna, P., Marichal, P., Vandenbossche, H., and Williamson, P. R. Study of fluconazole resistance in Cryptococcus neoformans by insertional mutagenesis. 99th Abstr. Gen. Meet. Am. Soc. Microbiol., May 30—June 3, 6, abstract A29, 1999.Google Scholar
  256. 255.
    Georgiev, V. St. Opportunistic/nosocomial infections: treatment and developmental therapeutics. II. Cryptococcosis. Med. Res. Rev, 13, 507–527, 1993.CrossRefGoogle Scholar
  257. 256.
    Van Cutsem, J. and Cauwenbergh, G. Results of itraconazole treatment in systemic mycoses in animals and man, in Recent Progress in Antifungal Chemotherapy, Yamaguchi, H., Kobayashi, G. S., and Takahashi, H., Eds. Marcel Dekker, New York, 203, 1992.Google Scholar
  258. 257.
    Viviani, M. A., Tortorano, A. M., Giani, P. C., et al. Itraconazole for cryptococcal infection in the acquired immunodeficiency syndrome. Ann. Intern. Med, 106, 106, 1987.Google Scholar
  259. 258.
    Viviani, M. A., Tortorano, A. M., Langer, M., et al. Experience with itraconazole in cryptococcosis and aspergillosis. J. Infect, 18, 151, 1989.PubMedCrossRefGoogle Scholar
  260. 259.
    Denning, D. W., Tucker, R. M., Hanson, L. H., Hamilton, J. R., and Stevens, D. A. Itraconazole therapy for cryptococcal meningitis and cryptococcosis. Arch. Intern. Med, 149, 2301, 1989.PubMedCrossRefGoogle Scholar
  261. 260.
    Denning, D. W., Tucker, R. M., Hanson, L. H., and Stevens, D. A. Itraconazole in opportunistic mycoses: cryptococcosis and aspergillosis. J. Am. Acad. Dermatol, 3, 602, 1990.CrossRefGoogle Scholar
  262. 261.
    de Gans, J., Eeftinck Schattenkerk, J. K. M., and van Ketel, R. J. Itraconazole as maintenance treatment for cryptococcal meningitis in the acquired immunodeficiency syndrome. Br. Med. J, 296, 339, 1988.CrossRefGoogle Scholar
  263. 262.
    Batungwanayo, J., Taelman, H., Bogaerts, J., et al. Pulmonary cryptococcosis associated with HIV-1 infection in Rwanda: a retrospective study of 37 cases. AIDS, 8, 1271, 1994.Google Scholar
  264. 263.
    Sato, T., Koseki, S., Takahashi, S., and Maie, O., Localized cutaneous cryptococcosis successfully treated with itraconazole: review of medication in 18 cases reported in Japan. Mycoses, 33, 455, 1990.PubMedGoogle Scholar
  265. 264.
    Goh, C. L., Cutaneous cryptococcosis successfully treated with itraconazole. Cutis, 51, 377, 1993.PubMedGoogle Scholar
  266. 265.
    Bettoli, V., Virgili, A., Zampino, M. R., Bedetti, A., and Montanari, P., Cutaneous cryptococcosis in AIDS: successful treatment with itraconazole. Mycoses, 36, 433, 1993.PubMedCrossRefGoogle Scholar
  267. 266.
    USPHS/IDSA guidelines for the prevention of opportunistic infections on persons infected with human immunodeficient virus. Infect. Dis. Obstetr. Gynecol, 8, 5–74, 2000 Clin. Infect. Dis, 30 (Suppl. 1), S29 — S65, 2000.Google Scholar
  268. 267.
    Powderly, W. G., Finkelstein, D. M., Feinberg, J., et al. A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection. N. Engl. J. Med, 332, 700–705, 1995.PubMedCrossRefGoogle Scholar
  269. 268.
    Schuman, P., Capps, L., Peng, G., et al. Weekly fluconazole for the prevention of mucosal candidiasis in women with HIV infection: a randomized, double-blind, placebo-controlled trial. Ann. Intern. Med, 126, 689–696, 1997.PubMedGoogle Scholar
  270. 269.
    Havlir, D. V., Dube, M. P., McCutchan, J. A., et al. Prophylaxis with weekly versus daily fluconazole for fungal infections in patients with AIDS. Clin. Infect. Dis, 27, 1369–1375, 1998.PubMedCrossRefGoogle Scholar
  271. 270.
    Lewis, J. L. and Rabinovich, S. The wide spectrum of cryptococcal infections. Am. J. Med, 53, 315, 1972.PubMedCrossRefGoogle Scholar
  272. 271.
    Lalloo, D., Fisher, D., Naraqi, S., et al. Cryptococcal meningitis (C. neoformans var.gattii) leading to blindness in previously healthy Melanesian adults in Papua New Guinea. Q. J. Med, 87, 343, 1994.Google Scholar
  273. 272.
    Currie, B., Vigus, T., Leach, G., and Dwyer, B. Cryptococcus neoformans var. gattii. Lancet, 336, 1442, 1990.Google Scholar
  274. 273.
    Laurenson, I. F., Naraqi, S., Howcroft, N., Burrows, I., and Saulei, S. Cryptococcal meningitis in Papua New Guinea: ecology and the role of eucalypts. Med. J. Aust, 158, 213, 1993.PubMedGoogle Scholar
  275. 274.
    Laurenson, I. F., Naraqi, S., Trevett, A., et al. Cryptococcal investigations in Papua New Guinea. Proc. 2nd Int. Conf. Cryptococcus Cryptococcosis, Milan, 114, 1993.Google Scholar
  276. 275.
    Laurenson, I. F., Trevett, A. J., Lalloo, D. G., et al. Meningitis caused by Cryptococcus neoformans var. gattii and var. neoformans in Papua New Guinea. Trans. R. Soc. Trop. Med. Hyg, 90, 57, 1996.PubMedCrossRefGoogle Scholar
  277. 276.
    Castanon-Olivares, L. R., Arreguin-Espinosa, R., Ruiz-Palacios y Santos, G., and Lopez- Martinez, R. Frequency of Cryptococcus species and varieties in Mexico and their comparison with some Latin American countries. Rev. Latinoam. Microbiol, 42, 35–40, 2000.PubMedGoogle Scholar
  278. 277.
    Kwon-Chung, K. J. and Bennett, J. E. Epidemiologic differences between the two varieties of Cryptococcus neoformans. Am. J. Epidemiol., 120, 123, 1984.PubMedGoogle Scholar
  279. 278.
    Ellis, D. H. Cryptococcus neoformans var. gattii in Australia. J. Clin. Microbiol, 25, 430, 1987.PubMedGoogle Scholar
  280. 279.
    Marriott, D. J., Speed, B. R., Spelman, D., Shaw, D., French, M., and Harkness, J. L. Cryptococcus neoformans var. gattii infections in Australian HIV-infected patients: a review of seven cases. 8th Annu. Conf. Australs. Soc. HIV Med., Nov. 14–17, 86, abstract 88, 1996.Google Scholar
  281. 280.
    Sorrell, T. C., Brownlee, A. G., Ruma, P., Malik, R., Pfeiffer, T. J., and Ellis, D. H. Natural environmental sources of Cryptococcus neoformans var. gattii. J. Clin. Microbiol, 34, 1261, 1996.Google Scholar
  282. 281.
    Pfeiffer, T. J. and Ellis, D. H. Environmental isolation of Cryptococcus neoformans var. gattii from Eucalyptus tereticornis. J. Med. Vet. Mycol, 30, 407, 1992.CrossRefGoogle Scholar
  283. 282.
    Sorrell, T. C., Chen, S. C. A., Ruma, P., et al. Concordance of clinical and environmental isolates of Cryptococcus neoformans var. gattii by random amplification of polymorphic DNA analysis and PCR fingerprinting. J. Clin. Microbiol, 34, 1253, 1996.PubMedGoogle Scholar
  284. 283.
    Kwon-Chung, K. J., Wickes, B. L., Stockman, L., Roberts, G. D., Ellis, D., and Howard, D. H. Virulence, serotype, and molecular characteristics of environmental strains of Cryptococcus neoformans var. gattii. Infect. Immun, 60, 1869, 1992.Google Scholar
  285. 284.
    Varma, A., Swinne, D., Staib, F., Bennett, J. E., and Kwon-Chung, K. J. Diversity of DNA fingerprints in Cryptococcus neoformans. J. Clin. Microbiol, 33, 1807, 1995.Google Scholar
  286. 285.
    Mitchell, D. H., Sorrell, T. C., Allworth, A. M., et al. Cryptococcal disease of the CNS in immunocompetent hosts: influence of cryptococcal variety on clinical manifestations and outcome. Clin. Infect. Dis, 20, 611, 1995.PubMedCrossRefGoogle Scholar
  287. 286.
    Speed, R. and Dunt, D. Clinical and host differences between the two varieties of Cryptococcus neoformans. Clin. Infect. Dis, 21, 28, 1995.CrossRefGoogle Scholar
  288. 287.
    Slobodnik, R. and Naraqi, S. Cryptococcal meningitis, in the Central Province of Papua New Guinea. Papua New Guinea Med. J., 23, 111, 1980.Google Scholar
  289. 288.
    Peetermans, W., Bobbaers, H., Verhaegen, J., and Vandepitte, J. Fluconazole-resistant Cryptococcus neoformans var. gattii in an AIDS patient. Acta Clin. Belg, 48, 405–409, 1993.PubMedGoogle Scholar
  290. 289.
    Kamei, K., Brummer, E., Nishimura, K., and Miyaji, M. Activity of voriconazole against Cryptococcus neoformans var. gattii vs. var. neoformans: effect of human serum. Abstr. 98th Gen. Meet. Am. Soc. Microbiol., May 17–21, 270, abstract F-100, 1998.Google Scholar
  291. 290.
    Gluck, J. L., Myers, J. P., and Pass, L. M. Cryptococcemia due to Cryptococcus albidus. South. Med. J, 80, 511, 1987.CrossRefGoogle Scholar
  292. 291.
    Gordon, M. A. Pulmonary cryptococcosis: a case due to Cryptococcus albidus. Am. Rev. Respir. Dis, 106, 786, 1972.Google Scholar
  293. 292.
    Lin, S. R., Peng, C. E., Yung, S. A., and Yu, H. S. Isolation of Cryptococcus albidus var. albidus in patient with pemphigus foliaceous. Kao-Hsiung I Hsueh Ko Hsueh Tsa Chih, 5, 126, 1989.PubMedGoogle Scholar
  294. 293.
    Weiser, H. G. Zur frage der pathogenität der Cryptococcus albidus. Schweiz. Med. Wochenschr, 103, 475, 1973.Google Scholar
  295. 294.
    da Cunha, T. and Lusins, J. Cryptococcus albidus meningitis. South. Med. J, 66, 1230, 1973.Google Scholar
  296. 295. Mello, J. C., Srinivasan, S., Scott, M. L., and Raff, M. J Cryptococcus albidus meningitis J. Infect., 2, 79, 1980Google Scholar
  297. 296.
    Krumholz, R. A. Pulmonary cryptococcosis: a case due to Cryptococcus albidus. Am. Rev. Respir. Dis, 105, 421, 1972.Google Scholar
  298. 297.
    Horowitz, I. D., Blumberg, E. A., and Krevolin, L. Cryptococcus albidus and mucormycosis empyema in a patient receiving hemodialysis. South. Med. J., 86, 1070, 1993.Google Scholar
  299. 298.
    Mckee, M., Arthington-Skaggs, B. A., Motley, M., et al. Distribution of yeast isolates recovered from the oral mucosa of HIV+ patients: relationship to antifungal drug use. Abstr. 99th Gen. Meet. Am. Soc. Microbiol., May 30—June 3, 137, abstract C-I61, 1999.Google Scholar
  300. 299.
    Loison, J., Bouchara, J. P., Gueho, E., et al. First report of Cryptococcus albidus septicemia in an HIV patient. J. Infect, 33, 139, 1996.PubMedCrossRefGoogle Scholar
  301. 300.
    Kordossis, T., Avlami, A., Velegraki, A., et al. First report of Cryptococcus laurentii meningitis and a fatal case of Cryptococcus albidus cryptococcaemia in AIDS patients. Med. Mycol, 36, 335–339, 1998.PubMedGoogle Scholar
  302. 301.
    Lynch III, J. P., Schaberg, D. R., Kissner, D. G., and Kauffman, C. A. Cryptococcus laurentii lung abscess. Am. Rev. Respir. Dis, 123, 135, 1981.PubMedGoogle Scholar
  303. 302.
    Chander, J., Sapra, R. K., and Talwar, P. Incidence of cryptococcosis in and around Chandigarch, India during the period 1982–1991. Mycoses, 37, 23, 1994.PubMedCrossRefGoogle Scholar
  304. 303.
    Custis, P. H., Haller, J. A., and de Juan, E. Jr. An unusual case of cryptococcal endophthalmitis. Reina, 15, 300, 1995.Google Scholar

Copyright information

© Springer Science+Business Media New York 2003

Authors and Affiliations

  • Vassil St. Georgiev
    • 1
  1. 1.National Institute of Allergy and Infectious DiseasesNational Institutes of HealthBethesdaUSA

Personalised recommendations